| Shared and distinct mechanisms of fibrosis JHW Distler, AH Györfi, M Ramanujam, ML Whitfield, M Königshoff, ... Nature Reviews Rheumatology 15 (12), 705-730, 2019 | 457 | 2019 |
| Targeting TGF-β signaling for the treatment of fibrosis AH Györfi, AE Matei, JHW Distler Matrix biology 68, 8-27, 2018 | 245 | 2018 |
| The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis A Zehender, J Huang, AH Györfi, AE Matei, T Trinh-Minh, X Xu, YN Li, ... Nature communications 9 (1), 3259, 2018 | 111 | 2018 |
| Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis A Soare, HA Györfi, AE Matei, C Dees, S Rauber, T Wohlfahrt, CW Chen, ... Arthritis & Rheumatology 72 (1), 137-149, 2020 | 102 | 2020 |
| Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells C Bergmann, F Müller, JHW Distler, AH Györfi, S Völkl, M Aigner, ... Annals of the Rheumatic Diseases 82 (8), 1117-1120, 2023 | 71 | 2023 |
| 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 67 | 2021 |
| TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy A Zehender, YN Li, NY Lin, A Stefanica, J Nüchel, CW Chen, HH Hsu, ... Nature communications 12 (1), 4404, 2021 | 60 | 2021 |
| Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators AE Matei, C Beyer, AH Györfi, A Soare, CW Chen, C Dees, C Bergmann, ... Annals of the rheumatic diseases 77 (3), 459-459, 2018 | 41 | 2018 |
| Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs AE Matei, CW Chen, L Kiesewetter, AH Györfi, YN Li, T Trinh-Minh, X Xu, ... Annals of the rheumatic diseases 78 (12), 1686-1692, 2019 | 40 | 2019 |
| Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation AH Györfi, AE Matei, M Fuchs, C Liang, AR Rigau, X Hong, H Zhu, ... Journal of Experimental Medicine 218 (9), e20201916, 2021 | 28 | 2021 |
| PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis Y Zhang, L Shen, H Zhu, K Dreissigacker, D Distler, X Zhou, AH Györfi, ... Annals of the Rheumatic Diseases 79 (9), 1227-1233, 2020 | 28 | 2020 |
| Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis AH Györfi, M Kopp, M May, M Vetter, M Uder, AE Kremer, G Schett, ... Annals of the Rheumatic Diseases 80 (6), e87-e87, 2021 | 26 | 2021 |
| Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies D Soteriou, M Kubánková, C Schweitzer, R López-Posadas, R Pradhan, ... Nature Biomedical Engineering 7 (11), 1392-1403, 2023 | 23 | 2023 |
| Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT C Treutlein, JHW Distler, K Tascilar, SC Fakhouri, AH Györfi, A Atzinger, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (6), 1629-1635, 2023 | 20 | 2023 |
| Impaired mitochondrial transcription factor a expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis X Zhou, T Trinh‐Minh, C Tran‐Manh, A Gießl, C Bergmann, AH Györfi, ... Arthritis & Rheumatology 74 (5), 871-881, 2022 | 18 | 2022 |
| Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153 YN Li, CW Chen, T Trinh-Minh, H Zhu, AE Matei, AH Györfi, F Kuwert, ... Bone research 10 (1), 51, 2022 | 16 | 2022 |
| Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale and testing the new 6-item Cochin hand functional disability scale in systemic … AM Gheorghiu, H Gyorfi, R Capota, A Matei, R Oneata, M Bojinca, ... JCR: Journal of Clinical Rheumatology 27 (3), 102-106, 2021 | 6 | 2021 |
| Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics A Rius Rigau, YN Li, AE Matei, AH Györfi, PM Bruch, S Koziel, ... Circulation Research 134 (7), 875-891, 2024 | 5 | 2024 |
| X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc) C Bergmann, L Hallenberger, SC Fakhouri, B Merlevede, A Brandt, ... Annals of the Rheumatic Diseases 80 (8), 1048-1056, 2021 | 5 | 2021 |
| Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease AH Györfi, T Filla, N Dickel, F Möller, YN Li, C Bergmann, AE Matei, ... Rheumatology 63 (4), 962-969, 2024 | 4 | 2024 |
Alexandru-Emil MateiPhD Student, FAU Erlangen-Nürnberg在 uk-erlangen.de 的电子邮件经过验证
Alexandru-Emil MateiPhD Student, FAU Erlangen-Nürnberg在 uk-erlangen.de 的电子邮件经过验证